Lillie Drenth

Associate | She/Her/Hers

Overview

Lillie Drenth is an associate in the Government Contracts Group in Crowell & Moring’s Washington, D.C. office. Lillie’s practice focuses on a range of government contract issues, including advising buyers and sellers in complex M&A transactions involving government contractors and representing contractors in internal and government investigations.

Lillie maintains an active pro bono practice, primarily focused on immigration issues.

While in law school, Lillie interned at the U.S. Court of Appeals for the Eleventh Circuit.

Career & Education

    • U.S. Court of Appeals for the Eleventh Circuit
      Intern, Honorable Adalberto Jordan, 2022
    • U.S. Court of Appeals for the Eleventh Circuit
      Intern, Honorable Adalberto Jordan, 2022
    • Emory University School of Law, J.D., 2024
    • University of Florida, B.A. in political science and economics, cum laude, 2021
    • Emory University School of Law, J.D., 2024
    • University of Florida, B.A. in political science and economics, cum laude, 2021
    • District of Columbia
    • District of Columbia
    • Spanish
    • Spanish

Lillie's Insights

Firm News | 2 min read | 05.22.26

Crowell & Moring Represents Kanders & Company in Acquisition of Ginkgo Bioworks’ Biosecurity Business

May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF)....

Lillie's Insights

Firm News | 2 min read | 05.22.26

Crowell & Moring Represents Kanders & Company in Acquisition of Ginkgo Bioworks’ Biosecurity Business

May 22, 2026: A Crowell & Moring team represented Kanders & Company in a complex carveout transaction in which Kanders acquired the biosecurity business of publicly traded Ginkgo Bioworks. The resulting company, Perimeter Systems, has launched as the world’s first integrated biosecurity infrastructure platform, designed to transform biological signals into real-time intelligence and accelerate decisive response. At closing, Perimeter secured $60 million in growth capital, led by Kanders in partnership with SCS Financial, Goldcrest Capital, Four Cities Capital, and the Safe Artificial Intelligence Fund (SAIF)....